38 Results

People

  1. Goldberg
    Goldberg
  2. Stein
    Stein
  3. Klimek
    Klimek
  4. Rampal
    Rampal
  5. Stahl
    Stahl
  6. Tallman
    Tallman
  7. Derkach
    Derkach
  8. Levine
    Levine
  9. Roshal
    Roshal
  10. Xiao
    Xiao

Groups

  1. Center for Hematologic Malignancies (27)
  2. Department of Medicine (27)
  3. Hematologic Malignancies, Division of (27)
  4. Adult Leukemia (23)
  5. Hematology-Oncology Fellows (9)
  6. Weinberg Fellows (8)
  7. Department of Pathology and Laboratory Medicine (6)
  8. GSK Faculty (6)
  9. Graduate Medical Education (6)
  10. Epidemiology and Biostatistics (5)
  1. "decitabine"
Formats
  1. Journal Article (26)
  2. Review (11)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (27)
  2. Department of Medicine (27)
  3. Hematologic Malignancies, Division of (27)
  4. Adult Leukemia (23)
  5. Hematology-Oncology Fellows (9)
  6. Weinberg Fellows (8)

More Groups

People
  1. Eytan Stein (9)
  2. Aaron Goldberg (6)
  3. Martin Tallman (6)
  4. Virginia Klimek (5)
  5. Maximilian Stahl (4)
  6. Raajit Rampal (4)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (9)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (5)

More Years

Publications
  1. Blood Advances (6)
  2. Leukemia and Lymphoma (4)
  3. Blood Reviews (3)
  4. Cancer (3)
  5. Expert Review of Hematology (2)
  6. Leukemia (2)

More Publications

Publishers
  1. American Society of Hematology (7)
  2. Taylor & Francis Group (6)
  3. Churchill Livingstone (3)
  4. Nature Publishing Group (3)
  5. Springer (3)
  6. Wiley Blackwell (3)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia
    Journal Article

    Ball, B.; Komrokji, R. S.; Adès, L.; Sekeres, M. A.; DeZern, A. E.; Pleyer, L.; Vey, N.; Almeida, A.; Germing, U.; Cluzeau, T.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Time to repeal and replace response criteria for acute myeloid leukemia?
    Journal Article

    Bloomfield, C. D.; Estey, E.; Pleyer, L.; Schuh, A. C.; Stein, E. M.; Tallman, M. S.; Wei, A.
    Blood Reviews (2018)

    Fulltext@MSK | Save
  • A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
    Journal Article

    Santini, V.; Allione, B.; Zini, G.; Gioia, D.; Lunghi, M.; Poloni, A.; Cilloni, D.; Sanna, A.; Masiera, E.; Ceccarelli, M.; more...
    Leukemia (2018)

    Fulltext@MSK | Save
  • Emerging therapeutic drugs for AML
    Journal Article

    Stein, E. M.; Tallman, M. S.
    Blood (2016)

    Fulltext@MSK | Save
  • A WIMSical approach to decoding DNA methylation in myeloid leukemia
    Journal Article

    Guryanova, O. A.; Levine, R. L.
    Genome Biology (2014)

    Fulltext@MSK | Save
  • Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Dolezal, E. K.; Tees, M. T.; Devlin, S. M.; Stein, K.; Romero, A.; Nimer, S. D.
    Leukemia Research (2012)

    Fulltext@MSK | Save
  • Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study
    Journal Article

    Kantarjlan, H.; Issa, J. P. J.; Rosenfeld, C. S.; Bennett, J. M.; Albitar, M.; DiPersio, J.; Klimek, V.; Slack, J.; De Castro, C.; Ravandi, F.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2′-deoxycytidine (decitabine) in 177 patients
    Journal Article

    Wijermans, P. W.; Lübbert, M.; Verhoef, G.; Klimek, V.; Bosly, A.
    Annals of Hematology (2005)

    Fulltext@MSK | Save